Hypertrophic cardiomyopathy: a practical approach to guideline directed management

Lancet. 2021 Dec 4;398(10316):2102-2108. doi: 10.1016/S0140-6736(21)01205-8. Epub 2021 Sep 30.

Abstract

Hypertrophic cardiomyopathy, one of the most common genetic cardiovascular conditions, will be encountered by nearly every health-care provider regardless of specialty. In 2020, new hypertrophic cardiomyopathy management guidelines were published, updating and evolving preceding versions. This Seminar provides a concise review and practical guide to the updated recommendations for patients with hypertrophic cardiomyopathy.

Publication types

  • Review

MeSH terms

  • Cardiac Myosins / genetics*
  • Cardiomyopathy, Hypertrophic / genetics
  • Cardiomyopathy, Hypertrophic / physiopathology*
  • Cardiomyopathy, Hypertrophic / therapy*
  • Carrier Proteins / genetics*
  • Echocardiography
  • Genetic Predisposition to Disease*
  • Guidelines as Topic*
  • Humans
  • Myosin Heavy Chains / genetics*

Substances

  • Carrier Proteins
  • MYH7 protein, human
  • myosin-binding protein C
  • Cardiac Myosins
  • Myosin Heavy Chains